AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://attachment.news.eu.nasdaq.com/a5eba1cbd5180f9694a463e54724225fbUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
